NCT06021405

Brief Summary

Psoriasis and lichen planus often occur at mechanically irritated skin sites (e.g. tight clothing). The investigators would like to investigate this phenomenon in more detail in this study. For this purpose, the skin is specifically irritated at a small and cosmetically favorable site by tearing off scotch tape or rubbing with a wooden spatula. In order to be able to examine the inflammatory processes caused by the irritation more closely, a small skin sample and a skin swab are taken from the irritated area. This skin sample and the swab are repeated after three and fourteen days.

Trial Health

15
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Sep 2025

Shorter than P25 for not_applicable

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 11, 2023

Completed
21 days until next milestone

First Posted

Study publicly available on registry

September 1, 2023

Completed
2 years until next milestone

Study Start

First participant enrolled

September 1, 2025

Completed
19 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 20, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 20, 2025

Completed
Last Updated

March 17, 2026

Status Verified

March 1, 2025

Enrollment Period

19 days

First QC Date

August 11, 2023

Last Update Submit

March 16, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Differences in the transcriptomic profile comparing psoriasis patients with and without induced koebner phenomenon

    Transcriptomic profile at all timepoints (reads per 55µm diameter dot)

    Day 0, Day 3 (optional), Day 14 (optional)

Secondary Outcomes (3)

  • Differences in the proteomic profile comparing psoriasis patients with and without induced koebner phenomenon

    Day 0, Day 3 (optional), Day 14 (optional)

  • Characterization of involved immune cells in the skin comparing psoriasis patients with and without induced koebner phenomenon

    Day 0, Day 3 (optional), Day 14 (optional)

  • Characterization of skin mikrobiome

    Day 0, Day 3, Day 14

Study Arms (1)

Tape stripping

EXPERIMENTAL
Procedure: Tape stripping

Interventions

a small area of skin will be tape-stripped with adhesive tape for up to 40 times and/or rubbed with a wooden spatula until the skin shows a slight erythema

Tape stripping

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Dermatologist diagnosed psoriasis (group psoriasis), lichen planus (group lichen planus) or no skin disease (group healthy controls)
  • Subject is capable of giving informed consent
  • Signed informed consent

You may not qualify if:

  • Use of systemic immunosuppressive/immunmodulating agents in the last three months
  • Use of topical anti-inflammatory treatment in the last 7 days in the area of sampling.
  • Phototherapy in the last 4 weeks
  • Active or recurrent serious bacterial, fungal or viral infection at the time of enrollment by patient history, including patients with Human Immunodeficiency Virus (HIV) infection, Hepatitis B and Hepatitis C infection, active or untreated latent tuberculosis.
  • Female patients of childbearing potential who are pregnant or breast feeding or planning a pregnancy during the duration of the trial and/or not practicing acceptable birth control for the duration of the trial
  • Known or suspected non-compliance, drug or alcohol abuse,
  • Inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, dementia, etc. of the participant,
  • Previous enrolment into the current study,
  • Enrolment of the investigator, his/her family members, employees and other dependent persons.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

PsoriasisLichen Planus

Condition Hierarchy (Ancestors)

Skin Diseases, PapulosquamousSkin DiseasesSkin and Connective Tissue DiseasesLichenoid Eruptions

Study Officials

  • Marie-Charlotte Brüggen, MD PhD

    University of Zurich

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Prof. Dr. med. PhD

Study Record Dates

First Submitted

August 11, 2023

First Posted

September 1, 2023

Study Start

September 1, 2025

Primary Completion

September 20, 2025

Study Completion

September 20, 2025

Last Updated

March 17, 2026

Record last verified: 2025-03